Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score (original) (raw)
Risk Models for Prediction of Implantable Cardioverter-Defibrillator Benefit
V. Le
Jacc-Heart Failure, 2019
View PDFchevron_right
Comparative Evaluation of Four Risk Scores for Predicting Mortality in Patients With Implantable Cardioverter-defibrillator for Primary Prevention
Rafael Peinado
Revista Española de Cardiología (English Edition), 2016
View PDFchevron_right
Identification of Patients Most Likely to Benefit From Implantable Cardioverter-Defibrillator Therapy : The Canadian Implantable Defibrillator Study
Andrew Krahn
Circulation, 2000
View PDFchevron_right
Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators
David Hodge
Heart Rhythm, 2012
View PDFchevron_right
Primary prevention implantable cardioverter–defibrillator treatment: how to identify patients most likely to benefit?
John Middleton
Expert Review of Cardiovascular Therapy, 2012
View PDFchevron_right
Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk Estimates
V. Le
JACC: Clinical Electrophysiology, 2018
View PDFchevron_right
Absolute risk reduction in total mortality with implantable cardioverter defibrillators: analysis of primary and secondary prevention trial data to aid risk/benefit analysis
Joseph de Bono
Europace, 2013
View PDFchevron_right
Prediction of Non-Arrhythmic Mortality in Primary Prevention Implantable Cardioverter Defibrillator Patients with Ischemic and Non-ischemic Cardiomyopathy
Pascal Defaye
JACC: Clinical Electrophysiology, 2015
View PDFchevron_right
Implantable Cardioverter-Defibrillator Registry Risk Score Models for Acute Procedural Complications or Death After Implantable Cardioverter-Defibrillator Implantation
David Haines
Circulation, 2011
View PDFchevron_right
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators
Inder Anand
Journal of the American College of Cardiology, 2017
View PDFchevron_right
Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators
Slava Polonsky
Heart Rhythm, 2009
View PDFchevron_right
Design of the Primary Prevention Parameters Evaluation (PREPARE) trial of implantable cardioverter defibrillators to reduce patient morbidity [NCT00279279]
Ann Fieberg
Trials, 2006
View PDFchevron_right
Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
Cynthia Tracy
Heart Rhythm, 2011
View PDFchevron_right
Application and comparison of the FADES, MADIT, and SHFM-D risk models for risk stratification of prophylactic implantable cardioverter-defibrillator treatment
Wayne Levy
EP Europace
View PDFchevron_right
Does the Implantable Cardioverter-Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients?
Wayne Levy
JACC. Clinical electrophysiology, 2017
View PDFchevron_right
Predictors of early mortality in implantable cardioverter-defibrillator recipients
Timothy Meyer, Francis Gilliam
Europace, 2009
View PDFchevron_right
Outcome of Primary Prevention Implantable Cardioverter Defibrillator Therapy According to New York Heart Association Functional Classification
Pascal Defaye
The American Journal of Cardiology, 2016
View PDFchevron_right
Clinical Risk Stratification for Primary Prevention Implantable Cardioverter Defibrillators
Eugene Crystal
Circulation: Heart Failure, 2015
View PDFchevron_right
Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit
Jafna Cox
Circulation. Arrhythmia and electrophysiology, 2012
View PDFchevron_right
Primary prevention of fatal ventricular arrhythmias with implantable cardioverter-defibrillator therapy--an analysis of implications based on MADIT II criteria
ashraf ali khan
McGill journal of medicine : MJM : an international forum for the advancement of medical sciences by students, 2006
View PDFchevron_right
Prevalence and Outcomes of Patients Receiving Implantable Cardioverter-Defibrillators for Primary Prevention Not Based on Guidelines
Randal Goldberg
The American Journal of Cardiology, 2015
View PDFchevron_right
Mortality risk score in primary prevention implantable cardioverter defibrillator recipients with non-ischaemic or ischaemic heart disease
Enno van der Velde
2010
View PDFchevron_right